PTGS2 and non-small cell lung carcinoma: We previously identified that the genetic polymorphisms in the COX-2 gene were associated with outcomes in patients with locally advanced NSCLC treated with chemoradiotherapy or radiotherapy alone.7 This concept is now confirmed for the first time in a prospective trial.